These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10925081)

  • 21. Efficacy of instillations with chemotherapy or immunotherapy following endoscopic resection for upper tract urothelial carcinoma.
    Bachir BG; Kassouf W
    Expert Rev Anticancer Ther; 2012 Jan; 12(1):63-75. PubMed ID: 22149433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ifosfamide, paclitaxel, and cisplatin for patients with advanced transitional cell carcinoma of the urothelial tract: final report of a phase II trial evaluating two dosing schedules.
    Bajorin DF; McCaffrey JA; Dodd PM; Hilton S; Mazumdar M; Kelly WK; Herr H; Scher HI; Icasiano E; Higgins G
    Cancer; 2000 Apr; 88(7):1671-8. PubMed ID: 10738226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical study of modified M-VAC therapy with one 21-day cycle for advanced urothelial cancer].
    Nakanishi S; Matsuzaki M; Morikawa H; Nakano M; Komatsu H
    Hinyokika Kiyo; 2004 Oct; 50(10):667-71. PubMed ID: 15575216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal selective cytology results predict recurrence of upper-tract transitional-cell carcinoma treated with ureteroscopic laser ablation.
    Boorjian S; Ng C; Munver R; Palese MA; Sosa RE; Vaughan ED; Del Pizzo JJ; Scherr DS
    J Endourol; 2004 Nov; 18(9):912-6. PubMed ID: 15659932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Outcome of treatment with surgical resection of the remaining tumor after modified M-VAC treatment for advanced urothelial carcinoma].
    Narita S; Nakano M; Matsuzaki M; Watanabe J; Morikawa H; Murata H; Oda H; Komatsu H
    Hinyokika Kiyo; 2005 Mar; 51(3):155-8. PubMed ID: 15852667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-intensification of MVAC with recombinant granulocyte colony-stimulating factor as initial therapy in advanced urothelial cancer.
    Seidman AD; Scher HI; Gabrilove JL; Bajorin DF; Motzer RJ; O'Dell M; Curley T; Dershaw DD; Quinlivan S; Tao Y
    J Clin Oncol; 1993 Mar; 11(3):408-14. PubMed ID: 7680373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous infusion, intravesical doxorubicin for the treatment of regionally advanced bladder cancer: a phase I-II trial.
    See WA; Dreicer R; Forest PK; Riggs C
    Am J Clin Oncol; 1997 Aug; 20(4):331-7. PubMed ID: 9256884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma.
    Dodd PM; McCaffrey JA; Mazumdar M; Scher H; Vlamis V; Higgins G; Herr H; Bajorin DF
    Cancer; 1999 Mar; 85(5):1145-50. PubMed ID: 10091800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration.
    Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Kabbani W; Langner C; Guo CC; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
    BJU Int; 2011 Oct; 108(8):1286-91. PubMed ID: 21332905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy for metastatic transitional carcinoma of the urinary tract. A prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis-platinum for failure.
    Tannock IF; Gospodarowicz M; Evans WK
    Cancer; 1983 Jan; 51(2):216-9. PubMed ID: 6681591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    Picozzi S; Ricci C; Gaeta M; Ratti D; Macchi A; Casellato S; Bozzini G; Carmignani L
    J Urol; 2012 Dec; 188(6):2046-54. PubMed ID: 23083867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoluminal instillation of epidoxorubicin as adjuvant treatment for upper urinary tract urothelial tumours.
    Ponchietti R; Neri B; Di Loro F; Raugei A
    Anticancer Res; 1996; 16(1):537-9. PubMed ID: 8615667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for poor prognosis patients with urothelial tumors and effect of dose intensity.
    Hibi H; Okamura K; Takashi M; Shimoji T; Miyake K
    Hinyokika Kiyo; 1997 Feb; 43(2):89-96. PubMed ID: 9086342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of upper tract urothelial tumors.
    Waidelich R; Hofstetter A; Stepp H; Baumgartner R; Weninger E; Kriegmair M
    J Urol; 1998 Feb; 159(2):401-4. PubMed ID: 9649248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful Treatment of Metastatic Upper Tract Urothelial Carcinoma With Vemurafenib: Case Report.
    Ji G; Qian Y
    Clin Genitourin Cancer; 2017 Aug; 15(4):e719-e721. PubMed ID: 28024948
    [No Abstract]   [Full Text] [Related]  

  • 37. "Extreme" renal preservation: neoadjuvant chemotherapy and percutaneous resection for upper-tract urothelial carcinoma in a patient with solitary kidney--a case report.
    Williams SK; Atalla C; Ghavamian R; Stein C; Hoenig DM
    J Endourol; 2013 Apr; 27(4):427-31. PubMed ID: 23442142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antegrade administration of mitomycin gel for upper tract urothelial carcinoma via percutaneous nephrostomy tube: a multi-institutional retrospective cohort study.
    Rose KM; Narang G; Rosen G; Labatte C; Dumitrascu CI; Campagna J; Yu A; Manley BJ; Spiess PE; Li R; Adibi M; Murray KS; Sexton WJ; Humphreys MR
    BJU Int; 2023 Apr; 131(4):471-476. PubMed ID: 36285629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study.
    Lucca I; Kassouf W; Kapoor A; Fairey A; Rendon RA; Izawa JI; Black PC; Fajkovic H; Seitz C; Remzi M; Nyirády P; Rouprêt M; Margulis V; Lotan Y; de Martino M; Hofbauer SL; Karakiewicz PI; Briganti A; Novara G; Shariat SF; Klatte T
    BJU Int; 2015 Jul; 116(1):72-8. PubMed ID: 24825476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective trial of ifosfamide, paclitaxel, and cisplatin in patients with advanced non-transitional cell carcinoma of the urothelial tract.
    Galsky MD; Iasonos A; Mironov S; Scattergood J; Donat SM; Bochner BH; Herr HW; Russo P; Boyle MG; Bajorin DF
    Urology; 2007 Feb; 69(2):255-9. PubMed ID: 17320659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.